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James May, MD, MS, FRACS, Sydney, Australia
By careful analysis of progressive computed tomography scans
during follow-up, Cho et al identified a staggering probability of
freedom from sac growth or re-expansion at 4 years of only 43%
after endovascular abdominal aortic aneurysm (AAA) repair with
the Excluder device (W. L. Gore & Associates). Inasmuch as all
measurements were prospectively performed by a single, experi-
enced endovascular surgeon, the intraobserver error, if tested, may
well have been less than the 5 mm arbitrarily chosen as significant.
It is possible therefore that the figure for freedom from sac growth
or re-expansion at 4 years may be even lower than 43%.
Of greater interest and concern is their finding that sac expan-
sion occurred in the absence of active endoleak in nine of 12
patients; the remaining three patients had type II endoleaks. Al-
though the cause of the aneurysm enlargement is not known, it
must be assumed, for patient safety, to be due to raised intrasac
pressure or endotension. There have been anecdotal reports of
endotension previously, but this is the first report of endotension
occurring in almost half of patients who received a single type of
endograft.While the method of the study is exemplary, one might
question the interpretation of the findings. The authors have made
an important observation, but appear to be intent on putting a
favorable spin on it. They state that the excellent early results, as
well as good late clinical outcomes, continue to justify the use of
this device. Considering that a patient with an expanding AAA sac
after endovascular repair is probably at the same risk for rupture as
if nothing had been done to treat the aneurysm in the first place, it
is difficult to recommend a device with a known probability of
failure of 57% at 4 years when there are other devices without this
impediment.
The freedom from rupture in this series would appear to be
related to the small size of the aneurysms at graft implantation
(mean, 50.5 mm) and the reduction in size of some aneurysms
before undergoing expansion. If the same rate of expansion con-
tinues as occurred in the third and fourth years of follow-up in this
study or the device is implanted in larger aneurysms, freedom from
rupture cannot be expected to last. Endovascular AAA repair
continues to evolve. If a problem is detected it needs to be
addressed, not minimized.INVITED COMMENTARY
Mark Fillinger, MD, Lebanon, NH
The study by Cho et al raises a number of interesting points,
mostly reflecting questions that remain unanswered about endo-
vascular repair in general. For example, there is nearly universal
agreement that aneurysm enlargement following endovascular re-
pair should be taken seriously. There is a lack of agreement,
however, about what specific steps to take when an aneurysm
enlarges with an endograft in place, especially if there is no obvious
endoleak. It is logical that aneurysm growth reflects pressurewithin the sac and, thus, a failure to fully “depressurize” the sac.
Many also assume that aneurysm growth with an endograft in place
implies a risk of rupture equivalent to that of an unrepaired
aneurysm, but this remains controversial.
This controversy is reflected in the Cho et al article, in which
the authors appropriately report a higher-than-expected incidence
of aneurysm enlargement with a specific endograft. As in many
reports regarding endotension, however, the small patient num-
